Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Using SVF enriched with PRP in surgery for certain fistulas is effective and safe.

Rosemary essential oil improved hair growth and thickness in UVB-exposed mice.

Woodhouse-Sakati Syndrome can include unique symptoms like liver issues and low growth hormone.

Ancient Chinese goats evolved cashmere-producing traits due to selective breeding, particularly in genes affecting hair growth.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.